PRME
Prime Medicine, Inc. · Healthcare
Arch Venture Partners Xii, LLC bought $10.0M of Prime Medicine, Inc.
10% owner
Bought$9,999,990
$3.30Price
3,030,300Shares
+20%Stake
What PRME did for a copier
- $1,000 copied at Mon, Aug 4 open, $4.35
- $1,074
- S&P 500, same days
- +5.5%
Measured over 30 trading days, to the Sep 16 close.
Arch Venture Partners Xii, LLC's record
7 other buys with 3 months of prices since 2023: on average +6.5% against the S&P 500, and 4 of 7 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Aug 1. Filed Fri, Aug 1, 7:19 PM ET, after the close. Returns use the Aug 4 open and the Sep 16 close. Not investment advice.